Question

What is familial hypercholesterolemia? Discuss its molecular basis, symptoms and treatments

10 Feb 2025
Answer :
Word Count : 737

Familial hypercholesterolemia (FH) is a genetic disorder characterized by abnormally high levels of cholesterol in the blood, particularly low-density lipoprotein cholesterol (LDL-C), leading to an increased risk of cardiovascular diseases. FH is inherited in an autosomal dominant pattern, meaning that only one copy of the defective gene, inherited from either parent, is sufficient to manifest the disease. Individuals with FH may develop early-onset atherosclerosis, heart attacks, and strokes due to the accumulation of cholesterol in the blood vessels.

### Molecular Basis of Familial Hypercholesterolemia

The molecular basis of FH primarily involves mutations in the *LDLR* (low-density lipoprotein receptor) gene, which is responsible for the synthesis of LDL receptors. These receptors are located on the surface of cells and are responsible for binding LDL particles, which carry cholesterol, and facilitating their removal from the bloodstream. In FH, mutations in the *LDLR* gene result in either a defective or absent LDL receptor, leading to an impaired ability to clear LDL cholesterol from the blood.

In addition to mutations in the *LDLR* gene, FH can also be caused by mutations in the *APOB* gene, which encodes apolipoprotein ____ _____ __________ ___ _________ ________ _________ _________ ____ _____.
__________ __________ _____ _________ __________ _______ ___ _________.
_______ ___ ____ _______ ______ ________ _______ ____ ______.
_________ ________ ______ ___ ________ ________ ___ _________ __________ ________ ______.
______ _______ ________ ________ ____.
____ ___ ______ ____ __________.
_____ _________ ___ ___ _______ ________ __________ _________ ______ ______ _______.
______ ___ __________ _________ _________.
___ __________ __________ ___ _______ _______.
___ ______ __________ _________ _______.
_________ ________ ________ ______ ______ __________ ____.
_______ ________ ________ _____ ___ ___ ___ ___ ______ _________ ___.
_______ ___ _________ _________ _______ _______ _____ _______ ___ ____ _______ ________.
___ ______ ____ ________ _____ __________ __________ _______ __________ _________ _______.
________ _____ ________ ______ ____ ___ ________ ______ ______ _______ ________.
________ _________ _________ _____ _____.
__________ __________ _____ ___ ___ _____.
______ _________ ______ __________ _______.
________ _______ ________ _________ _______ ______ __________.
________ ________ ________ _________ ___ ______ _____ ____.
_____ ________ _______ __________ ___ ______ ___ _______ ______ ___ ______.
____ ______ _____ ________ _______ ____ ____ _____ __________ ___.
________ _________ _____ ____ ___.
_____ ___ ____ ______ __________ _________ ________ ______ ___ ____ _________ ______.
________ ___ __________ ________ ______.
_____ __________ ______ ________ __________ ____ __________ ______ _______ ______ ____.
____ _____ ____ __________ __________ ____ ______ _________ __________ __________ _________.
________ _____ ___ ___ _________ _______ ____ __________ _______.
________ _____ _____ _____ ____ _______.
________ ____ _____ ___ ___ ______ _______ ____ _________.
_____ _____ ____ ______ ___ ___ ___ _________.
___ ______ ___ _____ ____ __________.
_________ ________ _____ _______ ________ ____ ___ _______.
____ ____ _________ ______ _______.
____ _______ ________ _______ __________ ___ ______ ____ _____.
_______ _______ __________ _______ ____ _______ __________.
______ ___ ___ ___ ____ ____ ____.
_________ _________ ________ _________ ____ ________ __________ _________ ___ _________.
___ _______ ________ ______ ______.
_______ _____ _________ __________ __________ __________ _______ _____ _____ ___.
____ ____ __________ _______ ____.
__________ _______ _____ _____ ______ _____ _______.
___ _________ __________ _____ _________ _________ ______ ________.
_________ _______ _____ ___ ___ _______ _____ ______.
_________ _______ ____ ________ _______ _________ ________ __________ ____.
_____ ________ ______ __________ ____ __________ ________ ________ ___ _________ ____ ______.
_____ ______ ______ _____ ___.
_____ _______ _____ ___ __________ __________ _____ ______ ______ ______ ___.
__________ ______ ___ ____ ________ __________.
_________ _____ _____ ___ _____.
__________ _____ ______ ____ ________ _______ ___ __________ ___ ___.
_______ ___ ____ ________ __________ _________ _________ __________ _________ ________ _________ ____.
______ ___ ___ ______ ____.
____ ______ _____ ____ ________ _______ __________ __________ ________ ______.
________ _______ _______ _________ _______ ___ ___ ______.
___ ____ _______ _____ ____ ____ _________ ________.
_______ ____ ___ ______ _____ _________.
_________ ____ _______ __________ _______ _________ ______ ________ _____ __________.
_________ __________ ____ _______ _________ ________ ____ _______ ______.
_________ ____ ______ ________ ___ ______ _____ ________ _____ ___.
____ ________ ________ _______ ______ ____ ___ _______.
___ __________ _______ _______ __________.
___ _____ __________ _________ _________ ________ _______ ____.
____ _________ _______ __________ ________ __________ _______ ____ ________ ____ ______ __________.
__________ _________ _______ ______ ____.
__________ ________ ___ _________ ______ ________ _________ __________ ________ ________.
_____ ______ _______ _________ ____ ______ ___ ________ _________ ___ ______ _____.
________ ________ ___ ____ __________ ________ __________.
Get Full Answer on WhatsApp

IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance What is familial hypercholesterolemia? Discuss its molecular basis, sy
🟢
WhatsApp Chat Fast live messaging
Email Us Business enquiries & support